179 related articles for article (PubMed ID: 37887554)
1. Correlation of High-Sensitivity Cardiac Troponin I Values and Cardiac Radiation Doses in Patients with Left-Sided Breast Cancer Undergoing Hypofractionated Adjuvant Radiotherapy with Concurrent Anti-HER2 Therapy.
Antunac K; Mayer L; Banovic M; Beketic-Oreskovic L
Curr Oncol; 2023 Oct; 30(10):9049-9062. PubMed ID: 37887554
[TBL] [Abstract][Full Text] [Related]
2. Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy.
Skyttä T; Tuohinen S; Boman E; Virtanen V; Raatikainen P; Kellokumpu-Lehtinen PL
Radiat Oncol; 2015 Jul; 10():141. PubMed ID: 26159409
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of radiation-induced cardiac toxicity in breast cancer patients treated with Trastuzumab-based chemotherapy.
Abouegylah M; Braunstein LZ; Alm El-Din MA; Niemierko A; Salama L; Elebrashi M; Edgington SK; Remillard K; Napolitano B; Naoum GE; Sayegh HE; Gillespie T; Farouk M; Ismail AA; Taghian AG
Breast Cancer Res Treat; 2019 Feb; 174(1):179-185. PubMed ID: 30478787
[TBL] [Abstract][Full Text] [Related]
4. Diastolic Dysfunction Occurs Early in HER2-Positive Breast Cancer Patients Treated Concurrently With Radiation Therapy and Trastuzumab.
Cao L; Cai G; Chang C; Miao AY; Yu XL; Yang ZZ; Ma JL; Zhang Q; Wu J; Guo XM; Chen JY
Oncologist; 2015 Jun; 20(6):605-14. PubMed ID: 25933931
[TBL] [Abstract][Full Text] [Related]
5. [Subclinical heart injury in patients receiving hypofractionated radiotherapy after breast conserving surgery: a preliminary analysis of prospective study].
Chen SY; Wang SL; Tang Y; Zhang JH; Qin SR; Huan FK; Li TT; Fang H; Song YW; Jin J; Liu YP; Qi SN; Chen B; Tang Y; Li N; Lu NN; Li YX
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):456-462. PubMed ID: 32575940
[No Abstract] [Full Text] [Related]
6. Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study.
De Sanctis V; Alfò M; Vitiello C; Vullo G; Facondo G; Marinelli L; Burocchi S; Gallo G; Valeriani M; Campanella B; Scalabrino G; Russo I; Salerno G; Cardelli P; Osti MF; De Biase L
Clin Breast Cancer; 2021 Jun; 21(3):e141-e149. PubMed ID: 33012660
[TBL] [Abstract][Full Text] [Related]
7. Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab.
Cao L; Cai G; Chang C; Yang ZZ; Feng Y; Yu XL; Ma JL; Wu J; Guo XM; Chen JY
Oncotarget; 2016 Jan; 7(1):1042-54. PubMed ID: 26460956
[TBL] [Abstract][Full Text] [Related]
8. Cardiac substructures exposure in left-sided breast cancer radiotherapy: Is the mean heart dose a reliable predictor of cardiac toxicity?
Naimi Z; Moujahed R; Neji H; Yahyaoui J; Hamdoun A; Bohli M; Kochbati L
Cancer Radiother; 2021 May; 25(3):229-236. PubMed ID: 33423965
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer.
Yu AF; Manrique C; Pun S; Liu JE; Mara E; Fleisher M; Patil S; Jones LW; Steingart RM; Hudis CA; Dang CT
Oncologist; 2016 Apr; 21(4):418-24. PubMed ID: 26984450
[TBL] [Abstract][Full Text] [Related]
10. Cardiac safety analysis of anti-HER2-targeted therapy in early breast cancer.
Zhang L; Wang Y; Meng W; Zhao W; Tong Z
Sci Rep; 2022 Aug; 12(1):14312. PubMed ID: 35995984
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity Assessment After Different Adjuvant Hypofractionated Radiotherapy Concurrently Associated with Trastuzumab in Early Breast Cancer.
Bonzano E; Guenzi M; Corvò R
In Vivo; 2018; 32(4):879-882. PubMed ID: 29936473
[TBL] [Abstract][Full Text] [Related]
12. Potential impact of cardiac dose-volume on acute cardiac toxicity following concurrent trastuzumab and radiotherapy.
Cao L; Hu WG; Kirova YM; Yang ZZ; Cai G; Yu XL; Ma JL; Guo XM; Shao ZM; Chen JY
Cancer Radiother; 2014 Mar; 18(2):119-24. PubMed ID: 24642505
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Early Radiation-Induced Changes in Left Ventricular Function by Myocardial Strain Imaging After Breast Radiation Therapy.
Yu AF; Ho AY; Braunstein LZ; Thor ME; Lee Chuy K; Eaton A; Mara E; Cahlon O; Dang CT; Oeffinger KC; Steingart RM; Liu JE
J Am Soc Echocardiogr; 2019 Apr; 32(4):521-528. PubMed ID: 30826225
[TBL] [Abstract][Full Text] [Related]
14. Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study).
Jacob S; Camilleri J; Derreumaux S; Walker V; Lairez O; Lapeyre M; Bruguière E; Pathak A; Bernier MO; Laurier D; Ferrieres J; Gallocher O; Latorzeff I; Pinel B; Franck D; Chevelle C; Jimenez G; Broggio D
Radiat Oncol; 2019 Feb; 14(1):29. PubMed ID: 30732640
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast Cancer.
Yu AF; Singh JC; Wang R; Liu JE; Eaton A; Oeffinger KC; Steingart RM; Hudis CA; Dang CT
Oncologist; 2017 Jun; 22(6):642-647. PubMed ID: 28341761
[TBL] [Abstract][Full Text] [Related]
16. No Acute Changes in LVEF Observed With Concurrent Trastuzumab and Breast Radiation With Low Heart Doses.
Bian SX; Korah MP; Whitaker TR; Ji L; Groshen S; Chung E
Clin Breast Cancer; 2017 Nov; 17(7):510-515. PubMed ID: 28412326
[TBL] [Abstract][Full Text] [Related]
17. Quantification of cardiac subvolume dosimetry using a 17 segment model of the left ventricle in breast cancer patients receiving tangential beam radiotherapy.
Tang S; Otton J; Holloway L; Delaney GP; Liney G; George A; Jameson M; Tran D; Batumalai V; Thomas L; Koh ES
Radiother Oncol; 2019 Mar; 132():257-265. PubMed ID: 30446318
[TBL] [Abstract][Full Text] [Related]
18. SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function.
Lynce F; Barac A; Tan MT; Asch FM; Smith KL; Dang C; Isaacs C; Swain SM
Oncologist; 2017 May; 22(5):518-525. PubMed ID: 28314836
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison between three-dimensional conformal radiotherapy followed by electron beam boost and volumetric modulated arc therapy using concomitant boost for the heart and cardiac segments in patients with left-sided breast cancer at risk for radiation-induced cardiac toxicity.
Murakami Y; Murakami Y; Kamima T; Oguchi M; Abo N; Takahashi T; Kaneko M; Nakano M; Matsubayashi F; Harada A; Taguchi S; Hashimoto T; Yoshioka Y
Phys Med; 2022 Mar; 95():126-132. PubMed ID: 35158316
[TBL] [Abstract][Full Text] [Related]
20. Dose-sparing effect of deep inspiration breath hold technique on coronary artery and left ventricle segments in treatment of breast cancer.
Song J; Tang T; Caudrelier JM; Bélec J; Chan J; Lacasse P; Aldosary G; Nair V
Radiother Oncol; 2021 Jan; 154():101-109. PubMed ID: 32950530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
